Literature DB >> 6129023

Vasoactive intestinal polypeptide: functional aspects.

J Fahrenkrug, P C Emson.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6129023     DOI: 10.1093/oxfordjournals.bmb.a071771

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  16 in total

1.  Plasma gut hormone levels in 37 patients with pheochromocytomas.

Authors:  A I Vinik; B Shapiro; N W Thompson
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

2.  Decreased REM sleep and altered circadian sleep regulation in mice lacking vasoactive intestinal polypeptide.

Authors:  Wang-Ping Hu; Jia-Da Li; Christopher S Colwell; Qun-Yong Zhou
Journal:  Sleep       Date:  2011-01-01       Impact factor: 5.849

Review 3.  Vasoactive intestinal peptide.

Authors:  S I Said
Journal:  J Endocrinol Invest       Date:  1986-04       Impact factor: 4.256

4.  Gastroenteropancreatic endocrine tumors.

Authors:  C Weil
Journal:  Klin Wochenschr       Date:  1985-05-15

5.  Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes.

Authors:  A Haegerstrand; B Jonzon; C J Dalsgaard; J Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Effects of vasoactive intestinal polypeptide (VIP) on renal function and plasma renin activity in the conscious rabbit.

Authors:  R Dimaline; W S Peart; R J Unwin
Journal:  J Physiol       Date:  1983-11       Impact factor: 5.182

Review 7.  Neuropeptides in dopamine-containing regions of the brain.

Authors:  A Albanese; M C Altavista
Journal:  Ital J Neurol Sci       Date:  1984-12

8.  Transcutaneous electrical nerve stimulation decreases lower esophageal sphincter pressure in patients with achalasia.

Authors:  M Guelrud; A Rossiter; P F Souney; M Sulbaran
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

9.  Effects of indomethacin and (+/-)-propranolol on the cardiovascular and renin responses to vasoactive intestinal polypeptide (VIP) infusion in man.

Authors:  R J Unwin; T Reed; S Thom; J Calam; W S Peart
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

10.  Changes of cerebral vasoactive intestinal polypeptide- and somatostatin-like immunoreactivity induced by noise and whole-body vibration in the rat.

Authors:  H Nakamura; T Moroji; H Nagase; T Okazawa; A Okada
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.